Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Xenetic Biosciences, Inc. (NASDAQ: XBIO)
XBIO Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-20.50%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
XBIO Stock Analysis
XBIO
PE Ratio:
XBIO
PEG Ratio:
Not Available
XBIO
Forward EPS Growth (12 month):
0.00%
XBIO
PS Ratio:
2
XBIO
PSG Ratio:
-0.1
XBIO
Forward Revenue Growth (12 month):
-16.70%
XBIO Articles
No data was found